Monoclonal Antibody Therapy in Treating Patients With Brain Metastases

Clinical trial NCT00002751 · COMPLETED

Trial details

NCT number: NCT00002751
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Cancer

Start date: 1989-07-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.